Wren Laboratories to Showcase Award-Winning Range of Live Culture Supplements at Arab Health 2023

23

Family-owned UK firm Wren Laboratories – the company behind one of the UK & Ireland’s most recommended brand of friendly bacteria supplements, Optibac Probiotics – will be showcasing at Arab Health 2023. 

Joining the ABHI UK Pavilion, the England-based business will exhibit its flagship range of award-winning probiotics, developed by prioritising highly researched strains and the most natural ingredients for optimal health benefits.

The brand has also recently undertaken a complete packaging refresh to reduce their impact on the environment, which has resulted in the end of plastic containers, plus the introduction of FSC-approved recyclable cartons across their entire product range.

Their award-winning supplements cater for a wide range of demographics including infants, children, adults and pregnant women. Offering 16 different best-in-class products, Optibac Probiotics span from daily digestion and immunity to more targeted support for conditions such as IBS, diarrhoea, constipation, urovaginal infections, colic, atopy, gestational diabetes and more. 

Sold in independent health food stores as well as reputable retail chains and pharmacies (including Boots, Waitrose, Tesco, Sainsbury’s and Selfridges) across the UK and Ireland, the range is also exported to 20+ countries worldwide, across Europe, North America and Asia. 

The business has gone from strength-to-strength, and in 2019, Optibac were proud winners of a Queen’s Award for Enterprise in recognition of outstanding international growth.

Dr Kate Stephens, PhD Food and Microbial Sciences; Gut Microbiology (University of Reading), BSc Medical Microbiology, commented: “Research and quality are the core of our products. Our supplements contain friendly bacteria proven to reach the gut alive and scientifically documented in randomised controlled clinical trials. The range is also formulated using the world’s most studied strains. We are excited to be joining ABHI at this year’s Arab Health and look forward to connecting with new distributors and healthcare professionals worldwide to showcase the unique benefits of our award-winning range of probiotic supplements, which prioritise the most natural ingredients and eco conscious packaging.”

Optibac offers supplements in a variety of formats, facilitating compliance – capsules, liquid drops, powder sachets and their brand-new gummies. The range also includes supplements suitable for vegan, dairy free and gluten free diets.

Among Optibac’s most recommended supplements is ‘For Women’ – with the renowned combination of Lactobacillus rhamnosus GR-1® and Lactobacillus reuteri RC-14®, the most researched probiotics for urogenital health. For Women contains strains that have been studied for over 30 years, clinically trialled in thousands of women and shown to support the vaginal microbiome, bacterial vaginosis, urinary tract infections and vaginal candidiasis (thrush).

Another best-selling Optibac supplement is Every Day EXTRA which contains the renowned L. acidophilus NCFM®, used in over 330 scientific studies including 68 human clinical trials. Every Day EXTRA sits within Optibac’s dailies range, and is formulated for general digestive and immune health as well as to provide extra support to those with IBS, allergies including hay fever and poor skin health.

The Arab Health Exhibition & Congress is taking place from 30 January – 2 February 2023 at the Dubai Convention and Exhibition Centre. Throughout the exhibition, 

Wren Laboratories will be located on the ABHI UK Pavilion – Stand H2 F78

About ABHI

ABHI is the UK’s leading industry association for health technology (HealthTech).

ABHI supports the HealthTech community to save and enhance lives. Members, including both multinationals and small and medium sized enterprises (SMEs), supply products from syringes and wound dressings to surgical robots and digitally enhanced technologies. We represent the industry to stakeholders, such as the government, NHS and regulators. HealthTech plays a key role in supporting delivery of healthcare and is a significant contributor to the UK’s economic growth. HealthTech is the largest employer in the broader Life Sciences sector, employing 145,700 people in 4,350 companies, with a combined turnover of £30bn. The industry has enjoyed growth of around 5% in recent years. ABHI’s 330 members account for approximately 80% of the sector by value.